ClinicalTrials.gg
Sign In

Polycystic Kidney Diseases clinical trials

The registry lists 59 studies for Polycystic Kidney Diseases across more than 10 countries. 12 are recruiting or about to start. 30 of them are mainly about Polycystic Kidney Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03. Counting its narrower condition Polycystic Kidney, Autosomal Dominant too: 218 studies, 50 open.

Get an email when these change. Save the Polycystic Kidney Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
33
Recruiting
11
Status unknown
6
Terminated
3
Withdrawn
2
Active, not recruiting
2

Phase

Phase 2
15
Phase 3
13
Phase 1
3
Early Phase 1
1
Phase 4
1

Where

United States
32
Italy
6
Netherlands
4
France
3
Germany
3
China
2

Who runs them

Otsuka Pharmaceutical Development & Commercialization, Inc. (4) · University of Kansas Medical Center (3) · Mario Negri Institute for Pharmacological Research (3) · Mayo Clinic (3) · The Rogosin Institute (2) · University of Cologne (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Asan Medical Center (2)

What is being tested here

Drugs under test in Polycystic Kidney Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tolvaptan124
Dapagliflozin111
Sirolimus024
XL647002
Telmisartan022
Niacinamide002
Lanreotide022
R-1,3-Butanediol-based Supplement001
Pravastatin001
Sodium Citrate001

Drug classes tested here mTOR inhibitors 5

Coming up

2phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 11 Polycystic Kidney Diseases studies recruiting now, 6 (55%) set no upper age limit and 5 (45%) stop at 75 or younger. 5 (45%) take children under 18. 1 (9%) are for women only and 0 (0%) for men only; 1 (9%) take healthy volunteers.

Recruiting studies that take each age, of 11
AgeWomenMen
105 (45%)4 (36%)
1811 (100%)10 (91%)
309 (82%)8 (73%)
408 (73%)7 (64%)
508 (73%)7 (64%)
657 (64%)6 (55%)
756 (55%)5 (45%)
856 (55%)5 (45%)

Across all 59 studies, recruiting or not: 47% stop at 75 or younger and 42% at 65; 25% take children; 2% are for women only and 0% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 59. Browse all 59 → or search them.